BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36913046)

  • 21. Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.
    Wu J; Zou T; Bai HX; Li X; Zhang Z; Xiao B; Nasrallah M; Karakousis G; Cao Y; Zhang PJ; Yang L
    Oncotarget; 2017 Sep; 8(40):69038-69046. PubMed ID: 28978179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma.
    Nathan JK; Brezzell AL; Kim MM; Leung D; Wilkinson DA; Hervey-Jumper SL
    J Neurooncol; 2017 Nov; 135(2):325-333. PubMed ID: 28744829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
    Mayer A; Schwanbeck C; Sommer C; Stockinger M; Giese A; Renovanz M; Vaupel P; Schmidberger H
    Strahlenther Onkol; 2015 Aug; 191(8):665-71. PubMed ID: 26025143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of survival outcomes in sinonasal squamous cell carcinoma: an analysis of the National Cancer Database.
    Farrell NF; Mace JC; Detwiller KY; Li R; Andersen PE; Smith TL; Clayburgh DR; Geltzeiler M
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1001-1011. PubMed ID: 33226198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical effects of microsurgery in spinal cord anaplastic astrocytoma].
    Zhang L; Jia WQ; Kong DS; Zhang ZF; Yang J
    Zhonghua Wai Ke Za Zhi; 2017 Jun; 55(6):441-445. PubMed ID: 28592077
    [No Abstract]   [Full Text] [Related]  

  • 26. Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma.
    Barnholtz-Sloan JS; Williams VL; Maldonado JL; Shahani D; Stockwell HG; Chamberlain M; Sloan AE
    J Neurosurg; 2008 Apr; 108(4):642-8. PubMed ID: 18377240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
    Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
    Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide.
    Shonka NA; Theeler B; Cahill D; Yung A; Smith L; Lei X; Gilbert MR
    J Neurooncol; 2013 Jun; 113(2):305-11. PubMed ID: 23526410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.
    Kizilbash SH; Giannini C; Voss JS; Decker PA; Jenkins RB; Hardie J; Laack NN; Parney IF; Uhm JH; Buckner JC
    J Neurooncol; 2014 Oct; 120(1):85-93. PubMed ID: 24993250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
    Hildebrand J; Gorlia T; Kros JM; Afra D; Frenay M; Omuro A; Stupp R; Lacombe D; Allgeier A; van den Bent MJ;
    Eur J Cancer; 2008 Jun; 44(9):1210-6. PubMed ID: 18248979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.
    Amsbaugh MJ; Yusuf M; Gaskins J; Burton E; Woo S
    J Clin Neurosci; 2019 Aug; 66():92-99. PubMed ID: 31104962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
    Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
    Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
    Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-Stage Glottic Carcinoma in the United States: Demographics and Treatment Choice.
    Friedman AD; Gengler I; Altaye M; Tabangin ME
    Laryngoscope; 2023 Apr; 133(4):901-907. PubMed ID: 35852500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
    Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
    Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
    Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis.
    Wong AT; Lee YC; Schwartz D; Lee A; Shao M; Han P; Choi K; Schreiber D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1171-1177. PubMed ID: 28574930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.